CHAIR
:
SPEAKER
(S):
Thomas Okarma, PhD, MD, President, CEO, Geron Corporation
Elizabeth L.R. Donley, President, Stemina Biomarker Discovery
George Dunbar, President & CEO, Aastrom Biosciences
Description
This panel will focus on the challenges of building a business around stem cells in an uncertain environment. This will address the practical, scientific, policy and commercial aspects of stem cell commercial development.
Objectives:
Expand understanding of the issues surrounding the commercialization of stem cell–based technologies, and sort out the business development issues from the political and ethical background debates.
Provide new perspectives and insights regarding the practical integration of the issues and judgments that are faced in developing a business that utilizes stem cell technologies.
Explore business issues related to financing and access intellectual property.